Strategic Licensing and Business Development for Global Biotech
Nextbridge Bioadvisors is a partner-led advisory firm specializing in technology licensing, business development, and strategic planning and transactions across the life sciences
Our Value Propostion
Technology Evaluation & Market Assessment
Portfolio positioning, partnering strategy, and transaction readiness for companies at all stages of development.
Business Strategy
Partner identification, engagement strategy, diligence support, and transaction execution from first contact through closing.
IP Licensing
Strategic structuring, valuation, and negotiation of complex licenses and collaborations across therapeutic, platform, and diagnostic technologies.
Areas of Specialization
- Gene Editing & Advanced Genomic Technologies
- Therapeutics (Small Molecules, Biologics, Cell & Gene Therapy)
- Diagnostics & Research Tools
- Functional Genomics & Screening Platforms
- Enabling & Platform Technologies
Why Nextbridge?
All engagements are led by the firm’s principals. Clients work directly with experienced transaction professionals—not junior teams—ensuring judgment, discretion, and efficiency throughout the engagement.
- 1000+ transactions across global markets
- Experience with early-stage startups through public companies
- Extensive experience with complex IP landscapes
- Confidential and conflict-management advisory model
- C-suite and board level experience
Engage with senior advisors who understand both science and deal dynamics